NCT00002036已完成1 期
Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)
Abbott1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2001年8月31日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 试验地点
- 1
研究概览
简要总结
To investigate the potential benefit of providing passive immunity with hyperimmune anti-HIV human serum.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have:
- •Proof of HIV infection.
- •Diagnosis of asymptomatic HIV infection or early AIDS related complex (ARC) with no zidovudine (AZT) or other anti-HIV therapy. OR a diagnosis of AIDS and = or > 3 months of AZT therapy.
排除标准
- •Co-existing Condition:
- •Patients with the following conditions or symptoms are excluded:
- •HIV-induced neurological disease.
- •IgA negative.
- •Concurrent Medication:
- •Immunomodulating agents.
- •Steroids.
- •Interferons.
- •Patients with the following are excluded:
- •Active substance abuse.
- •Use of immunomodulating drugs such as steroids or interferons.
- •HIV-induced neurological disease.
- •IgA negative.
- •Required with a diagnosis of AIDS:
- •= or > 3 months of zidovudine (AZT) therapy.
- •Active substance abuse.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected ChildrenHIV InfectionsNCT00000827National Institute of Allergy and Infectious Diseases (NIAID)45
已完成
1 期
Evaluating the Safety of and Immune Response to an HIV Vaccine Followed by Booster, Administered by Two Devices, in HIV-Uninfected AdultsHIV InfectionsNCT01260727National Institute of Allergy and Infectious Diseases (NIAID)92
已完成
1 期
Safety of and Immune Response to an HIV-1 Vaccine (ALVAC-HIV vCP1521) in Infants Born to HIV Infected MothersHIV InfectionsNCT00098163National Institute of Allergy and Infectious Diseases (NIAID)60
已完成
1 期
Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected AdultsHIV InfectionsNCT00115960National Institute of Allergy and Infectious Diseases (NIAID)120
已完成
1 期
Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected AdultsHIV InfectionsNCT00073216National Institute of Allergy and Infectious Diseases (NIAID)96